If only 1% of the Pacific’s population was permitted to work permanently in Australia, this would bring more benefits to the region than Australia’s annual aid contribution.
Massive borrowing to fund NZ’s economic recovery due to COVID-19 cannot be written off without the risk of worsening the crisis it was designed to meet.
Remittances to countries like Mexico, Pakistan and Vietnam are keeping pace with 2019’s record levels or in some cases rising, despite spring forecasts of a 20% decline.
During the break in competition caused by COVID-19, sportswomen lost wages, trained less and had poorer access to equipment than their male counterparts
The government has boosted funding for mental health services in light of the pandemic. But will these extra services get to where they are most needed?
Current housing stimulus measures aim to boost buyer demand and are too small to sustain a recovery. A second round of stimulus is likely to be needed, and it should go into social housing supply.
No news isn’t necessarily good news. News is powerful, and helps us to stay connected and informed. But it’s important we regulate our news consumption - particularly during times of crisis.
People are seen at the Mount Pleasant farmers market in Vancouver, B.C., where measures are in place to limit the number of people permitted at a time due to COVID-19.
THE CANADIAN PRESS/Darryl Dyck
Since the beginning of the COVID-19 pandemic, there has been an increased interest in local food. This demand could be leveraged to help develop community resilience and encourage healthier diets.
More people are wearing masks and using hand sanitisers.
Fani Mahuntsi/Gallo Images via Getty Images
As lockdown restrictions are relaxed, it is key to continue high-impact non-pharmaceutical interventions that will not impede economic activity, but limit the spread of COVID-19.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand